CTOR — Citius Oncology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Citius Oncology, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 September 30th
Period Length:	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	—	0.289	0.033	0
Total Inventory
Prepaid Expenses
Total Current Assets	—	0.377	0.058	11
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	0.126	68.2	72.6	84.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.137	0.032	2.05	32.7
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	0.137	0.032	2.05	38.2
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.01	68.2	70.6	46.1
Total Liabilities & Shareholders' Equity	0.126	68.2	72.6	84.4
Total Common Shares Outstanding